Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension
— Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension
by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today
June 23, 2026
• 3 min read
The White House aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide.
White House Denies Report Linking Trump To Eli Lilly's Experimental Obesity Treatment: 'Not For The Presi
White House denies report Trump got access to experimental weight loss drug
White House denies Trump was mystery patient given early access to weight-loss drug
White House denies Trump is the mystery patient who got early access to obesity drug
White House Flips Out Over Report Trump May Be on Weight Loss Drug
Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient
White House Denies Trump Was Given Exclusive Weight Loss Drug
It Kinda Looks Like Trump Might Be Taking An Experimental Obesity Drug?
Is Trump getting Eli Lilly's retatrutide? ‘Breathless’ clip viral amid debunked ‘compassionate use’ rumor
Just Who Is the Mystery 79-Year-Old Patient Who Got Special Access to an Experimental Weight Loss Drug?
White House denies reports Trump received Eli Lilly's unapproved obesity drug retatrutide through an FDA program.
The White House denied that the single approval of Eli Lilly's highly-anticipated weight loss drug retatrutide was for Trump…
Stay up to date with notifications from The IndependentNotifications can be managed in browser…
A White House spokesman said theories that President Trump sought the drug were ‘baseless speculation’
A stunning report reveals the president may have gotten an early access to an obesity drug to treat major medical issues.
Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented…
